• PROTEOMICS AND GENOMICS

    from the same FFPE tissue

    learn more
  • MOLECULAR ANALYSIS THAT MAXIMIZES

    actionable, accurate multiplex results from minimal tissue

    learn more
  • PATENTED LIQUID TISSUE TECHNOLOGY

    prepares both DNA & protein

    learn more

Absolute quantification of protein markers and Genomic Mutation identification for Solid Tumors

At OncoPlex Diagnostics, we know physicians must have access to laboratory diagnostics that support the best choice of a targeted therapy for each cancer patient. The accurate classification of a tumor by a clinical laboratory can mean longer survival and improved quality of life for patients.

Quantitative proteomics from FFPE tissue samples, available only from OncoPlex Diagnostics, is one of the most sensitive and specific cancer detection tools in the clinical laboratory today. Building on the power of patented Liquid Tissue technology, NGS-enabled genetic analysis is now available, giving  oncologists access to the most comprehensive characterization of actionable biomarkers within a patient's tumor. In this way, our tests provide unequivocal tumor classification, enabling physicians to apply appropriate cancer treatments and potentially help save lives. OncoPlex Diagnostics is a growing, CLIA-certified and CAP-certified laboratory dedicated to meeting the cancer diagnostic needs of pathologists and medical and surgical oncologists across the United States.